Latest Office News

Paradigm Biopharmaceuticals’ pivotal knee osteoarthritis trial fell below its pre-specified continuation threshold, leaving the ASX-listed biotech in voluntary administration with A$4.33 million in cash. Administrators now have up to three months to assess restructuring options, clinical data and the company’s future.

Spectur closed the September quarter with $762,000 in cash after a $1.10 million operating outflow, leaving it with an estimated 0.69 quarters of funding. The company is relying on cost savings, stronger seasonal receipts, collections of $1.1 million in receivables and a proposed $770,000 R&D tax credit advance to improve liquidity.

Caravel Minerals has completed the mining component of its Caravel Copper Project feasibility study, but the full DFS has slipped into the fourth quarter of 2026. The company is also reviewing process plant costs while holding $16.8 million in cash and reporting an estimated 4.6 quarters of funding at the quarter’s outflow rate.

Bathurst Resources lifted first-quarter consolidated EBITDA to NZ$9 million, helped by stronger export coal pricing and improved North Island domestic earnings. The miner held its FY27 EBITDA guidance at NZ$30 million to NZ$40 million while advancing two projects that could extend its operating life by up to 20 years.

Dotz Nano has secured commitments for a A$2 million placement while proposing to acquire PRF Technologies’ GridFeed software for US$1 million paid over 21 months. The move would broaden its energy strategy from building-level cooling optimisation into renewable generation, storage and grid analytics, but the deal and much of the commercial pipeline remain conditional.

Lion Selection Group’s FY2026 profit fell sharply from the prior year, but its Australian resources portfolio continued to expand, with post-tax NTA reaching 109.6 cents per share by 30 September. The investment company says its portfolio is positioned for an early-stage mining boom, while market valuations and unresolved litigation remain key risks.

Cokal has resumed mining and hauling at its 60%-owned Bumi Barito Mineral project after delayed Indonesian regulatory approval, but exceptionally low Barito River levels have pushed the next shipment to a tentative mid-November date. The company also bought three years of extra time on BBM's US$20 million repayment, while quarter-end cash stood at just US$193,000.

Spenda reported a sharp quarter-on-quarter improvement in operating cash flow, backed by A$4.2 million in annualised savings and a leaner workforce. But with A$876,000 in cash and an estimated 2.1 quarters of funding at the latest burn rate, the turnaround still has little room for delay.

Imugene reported an 86% overall response rate in its BTK inhibitor combination cohort, but ended September with only 0.70 quarters of estimated funding at the reported cash burn. The biotechnology company is assessing further capital sources while navigating a leadership transition and convertible note obligations.

Otto Energy ended the September quarter with US$25.6 million in cash and no debt, despite weaker commodity prices cutting revenue by 8%. Oil output rose, but the company’s next moves now hinge on shareholder approval of a proposed A$20 million capital return and separate strategies for its Gulf assets.

Orange Minerals has moved its 166km² Tepa Gold Project in Ghana into systematic exploration, but ended September with enough cash for an estimated 1.44 quarters of current outgoings. The company says it has not yet taken steps to raise more capital.

Centaurus Metals has advanced engineering, infrastructure and financing work at its Jaguar nickel project, while post-quarter offtake and strategic funding deals strengthen the path towards a Final Investment Decision. Its Boi Novo copper-gold project has also produced more than 20 drill-ready targets, but the company remains dependent on completing its debt and broader funding package.